Expression of the human chondrocyte phenotype in vitro

1989 ◽  
Vol 25 (7) ◽  
pp. 659-668 ◽  
Author(s):  
Amy Lynn Aulthouse ◽  
Michael Beck ◽  
Edward Griffey ◽  
Julie Sanford ◽  
Karen Arden ◽  
...  
2009 ◽  
Vol 28 (4) ◽  
pp. 516-521 ◽  
Author(s):  
Hongjun Zheng ◽  
Francoise Gourronc ◽  
Joseph A. Buckwalter ◽  
James A. Martin

ChemInform ◽  
2008 ◽  
Vol 39 (11) ◽  
Author(s):  
Rosaria Ottana ◽  
Rosanna Maccari ◽  
Rosella Ciurleo ◽  
Maria Gabriella Vigorita ◽  
Anna Maria Panico ◽  
...  

2018 ◽  
Vol 24 ◽  
pp. 539-547 ◽  
Author(s):  
Xiong Qin ◽  
Pan Jin ◽  
Tongmeng Jiang ◽  
Muyan Li ◽  
Jiachang Tan ◽  
...  

Cells ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 347 ◽  
Author(s):  
Marta Anna Szychlinska ◽  
Giovanna Calabrese ◽  
Silvia Ravalli ◽  
Nunziatina Laura Parrinello ◽  
Stefano Forte ◽  
...  

Stem cell therapy and tissue engineering represent a promising approach for cartilage regeneration. However, they present limits in terms of mechanical properties and premature de-differentiation of engineered cartilage. Cycloastragenol (CAG), a triterpenoid saponin compound and a hydrolysis product of the main ingredient in Astragalus membranaceous, has been explored for cartilage regeneration. The aim of this study was to investigate CAG’s ability to promote cell proliferation, maintain cells in their stable active phenotype, and support the production of cartilaginous extracellular matrix (ECM) in human adipose-derived mesenchymal stem cells (hAMSCs) in up to 28 days of three-dimensional (3D) chondrogenic culture. The hAMSC pellets were cultured in chondrogenic medium (CM) and in CM supplemented with CAG (CAG–CM) for 7, 14, 21, and 28 days. At each time-point, the pellets were harvested for histological (hematoxylin and eosin (H&E)), histochemical (Alcian-Blue) and immunohistochemical analysis (Type I, II, and X collagen, aggrecan, SOX9, lubricin). After excluding CAG’s cytotoxicity (MTT Assay), improved cell condensation, higher glycosaminoglycans (sGAG) content, and increased cell proliferation have been detected in CAG–CM pellets until 28 days of culture. Overall, CAG improved the chondrogenic differentiation of hAMSCs, maintaining stable the active chondrocyte phenotype in up to 28 days of 3D in vitro chondrogenic culture. It is proposed that CAG might have a beneficial impact on cartilage regeneration approaches.


2010 ◽  
Vol 29 (3) ◽  
pp. 361-368 ◽  
Author(s):  
R.L. Smith ◽  
D.P. Lindsey ◽  
L. Dhulipala ◽  
A.H.S. Harris ◽  
S.B. Goodman ◽  
...  

2010 ◽  
Vol 18 ◽  
pp. S121
Author(s):  
P. Reboul ◽  
F. Cailotto ◽  
P. Netter ◽  
A. Bianchi ◽  
J.-Y. Jouzeau

2007 ◽  
Vol 15 (24) ◽  
pp. 7618-7625 ◽  
Author(s):  
Rosaria Ottanà ◽  
Rosanna Maccari ◽  
Rosella Ciurleo ◽  
Maria Gabriella Vigorita ◽  
Anna Maria Panico ◽  
...  

2016 ◽  
Vol 9 ◽  
pp. CMAMD.S29844
Author(s):  
Jessica Badendick ◽  
Owen Godkin ◽  
Benjamin Kohl ◽  
Carola Meier ◽  
Michal Jagielski ◽  
...  

Osteoarthritis (OA) might affect chondrocyte culture characteristics and complement expression. Therefore, this study addressed the interrelation between macroscopical and microscopical structure, complement expression, and chondrocyte culture characteristics in non-OA and OA cartilage. Femoral head cartilage samples harvested from patients with femoral neck fractures (FNFs) and OA were analyzed for macroscopical alterations using an in-house scoring system, graded histologically (Mankin score), and immunolabeled for complement regulatory proteins (CRPs) and receptors. Morphology of monolayer cultured chondrocytes isolated from a subset of samples was assessed. The macroscopical score distinguished the FNF and OA cartilage samples and correlated significantly with the histological results. Chondrocyte phenotype from FNF or OA cartilage differed. Complement receptor C5aR, CRPs CD55 and CD59, and weakly receptor C3AR were detected in the investigated FNF and OA cartilage, except for CD46, which was detected in only two of the five investigated donors. The in-house score also allows inexperienced observers to distinguish non-OA and OA cartilage for experimental purposes.


Sign in / Sign up

Export Citation Format

Share Document